Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DHR

Danaher (DHR)

Danaher Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:DHR
DateTimeSourceHeadlineSymbolCompany
05/09/20246:00AMPR Newswire (US)Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological DiagnosisNYSE:DHRDanaher Corporation
05/07/20243:45PMPR Newswire (US)Danaher to Present at Bank of America Securities Healthcare ConferenceNYSE:DHRDanaher Corporation
05/07/20243:15PMPR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
05/03/20248:06AMPR Newswire (US)Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow CytometryNYSE:DHRDanaher Corporation
04/23/20245:00AMPR Newswire (US)Danaher Reports First Quarter 2024 ResultsNYSE:DHRDanaher Corporation
03/21/20243:15PMPR Newswire (US)Danaher Schedules First Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
02/27/20243:15PMPR Newswire (US)Danaher to Present at TD Cowen Health Care ConferenceNYSE:DHRDanaher Corporation
02/22/20243:15PMPR Newswire (US)Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction TargetsNYSE:DHRDanaher Corporation
02/21/20243:15PMPR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
02/05/20246:30AMPR Newswire (US)Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug DevelopmentNYSE:DHRDanaher Corporation
01/30/20245:00AMPR Newswire (US)Danaher Reports Fourth Quarter and Full Year 2023 ResultsNYSE:DHRDanaher Corporation
01/09/20246:30AMPR Newswire (US)Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform SolutionNYSE:DHRDanaher Corporation
01/08/20243:57PMDow Jones NewsDanaher Says 4Q Adjusted. Revenue to Fall by Less Than ForecastNYSE:DHRDanaher Corporation
01/08/20243:15PMPR Newswire (US)Danaher CEO to Comment on Financial PerformanceNYSE:DHRDanaher Corporation
01/02/20244:00PMPR Newswire (US)Danaher to Present at J.P. Morgan Healthcare ConferenceNYSE:DHRDanaher Corporation
12/21/20233:30PMPR Newswire (US)Danaher Schedules Fourth Quarter 2023 Earnings Conference CallNYSE:DHRDanaher Corporation
12/13/20233:06PMGlobeNewswire Inc.Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseNYSE:DHRDanaher Corporation
12/06/20236:30AMPR Newswire (US)Danaher Completes Acquisition of AbcamNYSE:DHRDanaher Corporation
12/05/20234:14PMDow Jones NewsDanaher Cuts Quarterly Dividend to 24 CentsNYSE:DHRDanaher Corporation
12/05/20233:30PMPR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
11/21/20233:15PMPR Newswire (US)Danaher to Present at Evercore ISI HealthCONx ConferenceNYSE:DHRDanaher Corporation
11/21/20231:22PMDow Jones NewsDanaher on Track for Largest Percent Increase in Almost a Year -- Data TalkNYSE:DHRDanaher Corporation
10/31/20236:30AMPR Newswire (US)Danaher appoints Christopher Riley to Executive Vice President for BiotechnologyNYSE:DHRDanaher Corporation
10/24/20235:41AMDow Jones NewsDanaher 3Q Earnings, Sales Decline but Beat EstimatesNYSE:DHRDanaher Corporation
10/24/20235:00AMPR Newswire (US)Danaher Reports Third Quarter 2023 ResultsNYSE:DHRDanaher Corporation
10/17/20235:34AMIH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNYSE:DHRDanaher Corporation
09/30/20237:00AMPR Newswire (US)Danaher Corporation Completes Separation of Veralto CorporationNYSE:DHRDanaher Corporation
09/28/20235:17PMPR Newswire (US)Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600NYSE:DHRDanaher Corporation
09/26/20233:15PMPR Newswire (US)Danaher Schedules Third Quarter 2023 Earnings Conference CallNYSE:DHRDanaher Corporation
09/19/20236:43AMPR Newswire (US)Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at CostNYSE:DHRDanaher Corporation
 Showing the most relevant articles for your search:NYSE:DHR